176 related articles for article (PubMed ID: 24482044)
1. MicroRNA‑34a/c function as tumor suppressors in Hep‑2 laryngeal carcinoma cells and may reduce GALNT7 expression.
Li W; Ma H; Sun J
Mol Med Rep; 2014 Apr; 9(4):1293-8. PubMed ID: 24482044
[TBL] [Abstract][Full Text] [Related]
2. MiR-154 inhibits the growth of laryngeal squamous cell carcinoma by targeting GALNT7.
Niu JT; Zhang LJ; Huang YW; Li C; Jiang N; Niu YJ
Biochem Cell Biol; 2018 Dec; 96(6):752-760. PubMed ID: 29874469
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of miR-34a contributes to the proliferation and migration of laryngeal carcinoma cells by targeting cyclin D1.
Ye J; Li L; Feng P; Wan J; Li J
Oncol Rep; 2016 Jul; 36(1):390-8. PubMed ID: 27220728
[TBL] [Abstract][Full Text] [Related]
4. miR-214 inhibits invasion and migration via downregulating GALNT7 in esophageal squamous cell cancer.
Lu Q; Xu L; Li C; Yuan Y; Huang S; Chen H
Tumour Biol; 2016 Nov; 37(11):14605-14614. PubMed ID: 27619677
[TBL] [Abstract][Full Text] [Related]
5. miR-370 targeted FoxM1 functions as a tumor suppressor in laryngeal squamous cell carcinoma (LSCC).
Yungang W; Xiaoyu L; Pang T; Wenming L; Pan X
Biomed Pharmacother; 2014 Mar; 68(2):149-54. PubMed ID: 24055400
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of MiR-206 promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression.
Zhang T; Liu M; Wang C; Lin C; Sun Y; Jin D
Anticancer Res; 2011 Nov; 31(11):3859-63. PubMed ID: 22110210
[TBL] [Abstract][Full Text] [Related]
7. RUNX3 inhibits laryngeal squamous cell carcinoma malignancy under the regulation of miR-148a-3p/DNMT1 axis.
Jili S; Eryong L; Lijuan L; Chao Z
Cell Biochem Funct; 2016 Dec; 34(8):597-605. PubMed ID: 27859417
[TBL] [Abstract][Full Text] [Related]
8. miR-1297 mediates PTEN expression and contributes to cell progression in LSCC.
Li X; Wang HL; Peng X; Zhou HF; Wang X
Biochem Biophys Res Commun; 2012 Oct; 427(2):254-60. PubMed ID: 22995297
[TBL] [Abstract][Full Text] [Related]
9. Hsa-miR-34c suppresses growth and invasion of human laryngeal carcinoma cells via targeting c-Met.
Cai KM; Bao XL; Kong XH; Jinag W; Mao MR; Chu JS; Huang YJ; Zhao XJ
Int J Mol Med; 2010 Apr; 25(4):565-71. PubMed ID: 20198305
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-34c-5p is related to recurrence in laryngeal squamous cell carcinoma.
Re M; Çeka A; Rubini C; Ferrante L; Zizzi A; Gioacchini FM; Tulli M; Spazzafumo L; Sellari-Franceschini S; Procopio AD; Olivieri F
Laryngoscope; 2015 Sep; 125(9):E306-12. PubMed ID: 26153151
[TBL] [Abstract][Full Text] [Related]
11. miR-24 functions as a tumor suppressor in Hep2 laryngeal carcinoma cells partly through down-regulation of the S100A8 protein.
Guo Y; Fu W; Chen H; Shang C; Zhong M
Oncol Rep; 2012 Apr; 27(4):1097-103. PubMed ID: 22139384
[TBL] [Abstract][Full Text] [Related]
12. Expression Levels and Clinical Significance of miR-21-5p, miR-let-7a, and miR-34c-5p in Laryngeal Squamous Cell Carcinoma.
Re M; Magliulo G; Gioacchini FM; Bajraktari A; Bertini A; Çeka A; Rubini C; Ferrante L; Procopio AD; Olivieri F
Biomed Res Int; 2017; 2017():3921258. PubMed ID: 29082244
[TBL] [Abstract][Full Text] [Related]
13. miR-375 exhibits a more effective tumor-suppressor function in laryngeal squamous carcinoma cells by regulating KLF4 expression compared with simple co-transfection of miR-375 and miR-206.
Guo Y; An R; Zhao R; Sun Y; Liu M; Tian L
Oncol Rep; 2016 Aug; 36(2):952-60. PubMed ID: 27279635
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-101 is a potential prognostic indicator of laryngeal squamous cell carcinoma and modulates CDK8.
Li M; Tian L; Ren H; Chen X; Wang Y; Ge J; Wu S; Sun Y; Liu M; Xiao H
J Transl Med; 2015 Aug; 13():271. PubMed ID: 26286725
[TBL] [Abstract][Full Text] [Related]
15. miR-205 promotes proliferation and invasion of laryngeal squamous cell carcinoma by suppressing CDK2AP1 expression.
Zhong G; Xiong X
Biol Res; 2015 Oct; 48():60. PubMed ID: 26515287
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-16 targets zyxin and promotes cell motility in human laryngeal carcinoma cell line HEp-2.
Wu H; Liu T; Wang R; Tian S; Liu M; Li X; Tang H
IUBMB Life; 2011 Feb; 63(2):101-8. PubMed ID: 21360639
[TBL] [Abstract][Full Text] [Related]
17. Promoter hypermethylation of miR-34a contributes to the risk, progression, metastasis and poor survival of laryngeal squamous cell carcinoma.
Shen Z; Zhou C; Li J; Ye D; Li Q; Wang J; Cui X; Chen X; Bao T; Duan S
Gene; 2016 Nov; 593(2):272-6. PubMed ID: 27450916
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of miR -155 promotes proliferation and invasion of human laryngeal squamous cell carcinoma via targeting SOCS1 and STAT3.
Zhao XD; Zhang W; Liang HJ; Ji WY
PLoS One; 2013; 8(2):e56395. PubMed ID: 23437123
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma.
Liu M; Wu H; Liu T; Li Y; Wang F; Wan H; Li X; Tang H
Cell Res; 2009 Jul; 19(7):828-37. PubMed ID: 19546886
[TBL] [Abstract][Full Text] [Related]
20. MiR-340 impedes the progression of laryngeal squamous cell carcinoma by targeting EZH2.
Yu W; Zhang G; Lu B; Li J; Wu Z; Ma H; Wang H; Lian R
Gene; 2016 Feb; 577(2):193-201. PubMed ID: 26656176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
